Overview
- 25 inspections across 23 sites are on record.
- 47 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-19.
At a glance
Inspections
25
Sites
23
Observations
47
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nova Pneuma, Inc. | 19 Dec 2025 | Human Drugs | |
| Kindeva Drug Delivery L.P. | 13 Nov 2025 | Human Drugs | On file |
| Preferred Pharmaceuticals, Inc. | 27 May 2025 | Human Drugs | On file |
| MeriCal LLC | 30 Apr 2025 | Human Drugs | On file |
| Element Materials Technology Pharma US LLC | 28 Mar 2025 | Human Drugs |
Sites inspected
Nova Pneuma, Inc.Fremont, United States1 insp.
Kindeva Drug Delivery L.P.Northridge, United States1 insp.
Preferred Pharmaceuticals, Inc.Anaheim, United States1 insp.
MeriCal LLCOrange, United States1 insp.
Element Materials Technology Pharma US LLCSanta Fe Springs, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Christopher M Jenner3 shared
Gunneet Kaur2 shared
Lillian S Wu2 shared
Lisa R Hilliard2 shared
Tareq W Haddad1 shared
Thuy Tram L Nguyen1 shared
Carolina D Vasquez1 shared
Darren S Brown1 shared
Seneca D Toms1 shared
Taichun Qin1 shared
Full investigator report
Get the verbatim findings behind Tiara M Brown's 47 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site